Table 1.

Treatment plan


Agents and doses/routes

Schedule
R-CDE  
    Rituximab, 375 mg/m2  Every 28 d just before the initiation of each cycle of CDE  
    Cyclophosphamide, 187.5-200 mg/m2/d for 4 d*  Repeat every 28 d for a maximum of 6 cycles  
    Doxorubicin, 12.5 mg/m2/d for 4 d*  
    Etoposide, 60 mg/m2/d for 4 d, continuous intravenous infusion over 96 h   
Colony-stimulating factor filgrastim (G-CSF), 5 μg/kg/d, subcutaneous injection   D 6 until neutrophil recovery  
Infection prophylaxis required  
    Trimethoprim-sulfamethoxazole, 160 mg/800 mg by mouth   3 times/wk  
    Fluconazole, 100 mg by mouth   Daily  
Central nervous system prophylaxis  
    Intrathecal methotrexate, 12 mg   D 1 of each cycle (n = 68)  
    OR   
Intrathecal cytarabine, 50 mg
 
D 1 and 4 of cycles 1 and 2 for patients with Burkitt lymphoma or bone marrow involvement only (n = 6)
 

Agents and doses/routes

Schedule
R-CDE  
    Rituximab, 375 mg/m2  Every 28 d just before the initiation of each cycle of CDE  
    Cyclophosphamide, 187.5-200 mg/m2/d for 4 d*  Repeat every 28 d for a maximum of 6 cycles  
    Doxorubicin, 12.5 mg/m2/d for 4 d*  
    Etoposide, 60 mg/m2/d for 4 d, continuous intravenous infusion over 96 h   
Colony-stimulating factor filgrastim (G-CSF), 5 μg/kg/d, subcutaneous injection   D 6 until neutrophil recovery  
Infection prophylaxis required  
    Trimethoprim-sulfamethoxazole, 160 mg/800 mg by mouth   3 times/wk  
    Fluconazole, 100 mg by mouth   Daily  
Central nervous system prophylaxis  
    Intrathecal methotrexate, 12 mg   D 1 of each cycle (n = 68)  
    OR   
Intrathecal cytarabine, 50 mg
 
D 1 and 4 of cycles 1 and 2 for patients with Burkitt lymphoma or bone marrow involvement only (n = 6)
 
*

The daily dose of cyclophosphamide and doxorubicin was admixed in the same bag of intravenous fluid (1 L) and was infused through a central venous catheter, and etoposide was diluted in a separate liter of intravenous fluid and infused through a separate central venous catheter or peripheral line.

or Create an Account

Close Modal
Close Modal